Literature DB >> 9098300

The importance of initial management in the treatment of severe infectious corneal ulcers.

S D McLeod1, L D LaBree, R Tayyanipour, C W Flowers, P P Lee, P J McDonnell.   

Abstract

PURPOSE: To identify factors that influence the outcome of patients with severe infectious corneal ulcers.
METHOD: A retrospective review was performed of the hospital records of all such patients admitted to the Doheny Eye Hospital during a 30 month period. Outcome variables examined were change in visual acuity, duration of hospitalization, hospital charges, and percentage of patients who required penetrating keratoplasty.
RESULTS: Sixty-two ulcers were included. An organism was identified and antibiotic sensitivities established in 52 patients (84%). Inpatient therapy involved a combination of fortified aminoglycoside and cephalosporin antibiotics in 39 patients (63%) and was found to be appropriate on the basis of sensitivity studies in 49 (94%) of 52 patients. Inappropriate initial treatment was related to increased hospital charge (P = 0.024) as well as increased risk of penetrating keratoplasty (P = 0.001).
CONCLUSIONS: Appropriate initial therapy is most critical in the course of serious corneal ulcers, and aggressive, broad-spectrum antibiotic coverage is advocated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9098300     DOI: 10.1016/s0161-6420(95)30771-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  23 in total

1.  Moraxella keratitis: predisposing factors and clinical review of 95 cases.

Authors:  S Das; M Constantinou; M Daniell; H R Taylor
Journal:  Br J Ophthalmol       Date:  2006-07-06       Impact factor: 4.638

Review 2.  In vivo imaging of corneal inflammation: new tools for clinical practice and research.

Authors:  Dimosthenis Mantopoulos; Andrea Cruzat; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

3.  Initial therapy for suppurative microbial keratitis in Iraq.

Authors:  Faiz Al-Shakarchi
Journal:  Br J Ophthalmol       Date:  2007-06-27       Impact factor: 4.638

4.  UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.

Authors:  Karim Makdoumi; Jes Mortensen; Omid Sorkhabi; Bo-Eric Malmvall; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-27       Impact factor: 3.117

5.  Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group.

Authors:  N Morlet; D Minassian; J Butcher
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

6.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

7.  Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

Authors:  Aiyin Chen; Lalitha Prajna; Muthiah Srinivasan; Rajendran Mahalakshmi; John P Whitcher; Stephen McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2008-01-22       Impact factor: 5.258

8.  Risk factors for perforation in microbial corneal ulcers in north India.

Authors:  J S Titiyal; S Negi; A Anand; R Tandon; N Sharma; R B Vajpayee
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

9.  Clinical review of corneal ulcers resulting in evisceration and enucleation in elderly population.

Authors:  Marios Constantinou; Vishal Jhanji; Lingwei William Tao; Rasik B Vajpayee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-28       Impact factor: 3.117

10.  Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases.

Authors:  T Bourcier; F Thomas; V Borderie; C Chaumeil; L Laroche
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.